Document is current
Any future updates will be listed below
-
Authors
Al-Hassany, Linda https://orcid.org/0000-0002-8699-7440
Lyons, Hannah S. https://orcid.org/0000-0003-0105-1064
Boucherie, Deirdre M. https://orcid.org/0000-0001-9354-715X
Farham, Fatemeh https://orcid.org/0000-0002-5120-309X
Lange, Kristin S. https://orcid.org/0000-0002-8056-8514
Marschollek, Karol https://orcid.org/0000-0001-9093-180X
Onan, Dilara https://orcid.org/0000-0001-9505-6135
Pensato, Umberto https://orcid.org/0000-0002-4042-4735
Storch, Elisabeth https://orcid.org/0000-0001-9937-3437
Torrente, Angelo https://orcid.org/0000-0002-0585-8351
Waliszewska-Prosół, Marta https://orcid.org/0000-0002-9074-2803
Reuter, Uwe https://orcid.org/0000-0002-8527-0725
,
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 28 December 2022
Accepted: 18 January 2023
First Online: 16 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: Linda Al-Hassany, Hannah S. Lyons, Deirdre M. Boucherie, Fatemeh Farham, Karol Marschollek, Dilara Onan, Umberto Pensato, Angelo Torrente, Marta Waliszewska-Prosół declare no conflict of interest. Kristin S. Lange has received travel and accommodation expenses from Acticor Biotech and TEVA GmbH, not related to the submitted work. Elisabeth Storch has received travel and accommodation expenses from TEVA GmbH, not related to the submitted work. Uwe Reuter has received consulting fees, research grants or fees for presentations from Abbie, Allegan, Amgen, Lilly, Lundbeck, Medscape, Novartis, Pfizer, StreaMedup, Teva and the German Government (BMBF). Uwe Reuter is treasurer of the European Headache Federation.
